32. Prevention: Clinical 1209-086

1209-086 - APPLYING REWIND CVD CRITERIA TO SUSTAIN 6 AND PIONEER 6: AN EXPLORATORY ANALYSIS OF CV OUTCOMES WITH SEMAGLUTIDE

Session
1209 - Prevention: Clinical 3
Speakers
Pathway
32. Prevention: Clinical
Presentation Number
1209-086
Presentation Rating
 |